NO20082729L - Etanol-presipiterte Phaseolus vulgaris ekstrakter, deres anvendelse og formuleringer - Google Patents

Etanol-presipiterte Phaseolus vulgaris ekstrakter, deres anvendelse og formuleringer

Info

Publication number
NO20082729L
NO20082729L NO20082729A NO20082729A NO20082729L NO 20082729 L NO20082729 L NO 20082729L NO 20082729 A NO20082729 A NO 20082729A NO 20082729 A NO20082729 A NO 20082729A NO 20082729 L NO20082729 L NO 20082729L
Authority
NO
Norway
Prior art keywords
ethanol
precipitated
formulations
phaseolus vulgaris
vulgaris extracts
Prior art date
Application number
NO20082729A
Other languages
English (en)
Other versions
NO346419B1 (no
Inventor
Ezio Bombardelli
Davide Berlanda
Marco Bertani
Fabio Donzelli
Andrea Gardi
Cesare Ponzone
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37888415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082729(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20082729L publication Critical patent/NO20082729L/no
Publication of NO346419B1 publication Critical patent/NO346419B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Ekstrakt som kan oppnås ved ekstraksjon fra Phaseolus sp. med blandinger av etanol og vann, særpreget ved et a-amylaseinhibitorinnhold på mellom 1.000 og 1.600 USP/mg (HPLC-titer mellom 6 og 14 % w/w) og et fytohemaglutinininnhold på mellom 8.000 og 30.000 HAU/g samt en fremgangsmåte for dets fremstilling.
NO20082729A 2005-12-22 2008-06-19 Etanol-presipiterte Phaseolus vulgaris ekstrakter, deres anvendelse og formuleringer NO346419B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002450A ITMI20052450A1 (it) 2005-12-22 2005-12-22 Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
PCT/EP2006/012012 WO2007071334A2 (en) 2005-12-22 2006-12-13 Ethanol-precipitated phaseolus vulgaris extracts, their use and formulations

Publications (2)

Publication Number Publication Date
NO20082729L true NO20082729L (no) 2008-07-08
NO346419B1 NO346419B1 (no) 2022-07-18

Family

ID=37888415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082729A NO346419B1 (no) 2005-12-22 2008-06-19 Etanol-presipiterte Phaseolus vulgaris ekstrakter, deres anvendelse og formuleringer

Country Status (17)

Country Link
US (2) US20090169657A1 (no)
EP (1) EP1962877B1 (no)
JP (1) JP5452931B2 (no)
KR (1) KR101449763B1 (no)
CN (1) CN101340923B (no)
AU (1) AU2006328983B2 (no)
BR (1) BRPI0620054A8 (no)
CA (1) CA2634345C (no)
DK (1) DK1962877T3 (no)
ES (1) ES2813929T3 (no)
IL (1) IL192292A (no)
IT (1) ITMI20052450A1 (no)
NO (1) NO346419B1 (no)
PT (1) PT1962877T (no)
RU (1) RU2426552C2 (no)
SI (1) SI1962877T1 (no)
WO (1) WO2007071334A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323815T3 (es) 2007-03-07 2009-07-24 Indena S.P.A. Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.
CN101555275B (zh) * 2009-05-08 2011-09-28 广东省食品工业研究所 一种利用生物酶法制备α-淀粉酶抑制剂的方法
KR20110138001A (ko) * 2010-06-18 2011-12-26 (주)아모레퍼시픽 유색콩 추출물을 함유하는 조성물
ITMI20121727A1 (it) 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
TW201427674A (zh) * 2013-01-15 2014-07-16 ji-min Song 花豆種子萃取物及其製備方法與用途
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts
US10098920B2 (en) * 2015-01-14 2018-10-16 Kutsanyan Akop Surikovych Method for producing a complex of biologically active substances exhibiting hypoglycemic activity
CN116270793A (zh) * 2023-02-07 2023-06-23 湖南朗林生物资源股份有限公司 一种白芸豆提取物的制备方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628757A1 (de) * 1976-06-26 1977-12-29 Guenter Dr Woeber Amylase inhibitor
JPH06116197A (ja) 1992-09-07 1994-04-26 Max Fuakutaa Kk 新規ラジカルスカベンジャー
GB9921229D0 (en) * 1999-09-08 1999-11-10 Med Eq As Compositions
US6797287B2 (en) * 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
US20060147565A1 (en) * 2002-06-28 2006-07-06 Pharmachem Laboratories, Inc. Purified amylase inhibitor and novel process for obtaining the same
US20040131749A1 (en) * 2002-08-29 2004-07-08 Archer-Daniels-Midland Company Phytochemicals from edible bean process streams
ITMI20040619A1 (it) * 2004-03-30 2004-06-30 Consiglio Nazionale Ricerche Estratto purificato di inibitore dell'alfa-amilasi da fagioli essenzialmente privi di fitoemoagglutinina procedimento di estrazione e composizioni che lo contengono
ES2323815T3 (es) * 2007-03-07 2009-07-24 Indena S.P.A. Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.
US7553502B2 (en) * 2007-03-07 2009-06-30 Indena S.P.A. Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity

Also Published As

Publication number Publication date
WO2007071334A2 (en) 2007-06-28
US20090169657A1 (en) 2009-07-02
CN101340923A (zh) 2009-01-07
CA2634345C (en) 2016-09-27
EP1962877B1 (en) 2020-07-22
ES2813929T3 (es) 2021-03-25
KR20080080127A (ko) 2008-09-02
NO346419B1 (no) 2022-07-18
AU2006328983B2 (en) 2012-06-28
JP5452931B2 (ja) 2014-03-26
ITMI20052450A1 (it) 2007-06-23
US11241470B2 (en) 2022-02-08
SI1962877T1 (sl) 2020-09-30
BRPI0620054A2 (pt) 2011-11-01
CA2634345A1 (en) 2007-06-28
BRPI0620054A8 (pt) 2018-12-26
PT1962877T (pt) 2020-09-04
IL192292A (en) 2013-05-30
AU2006328983A1 (en) 2007-06-28
CN101340923B (zh) 2013-11-06
DK1962877T3 (da) 2020-08-31
IL192292A0 (en) 2008-12-29
EP1962877A2 (en) 2008-09-03
US20170333508A1 (en) 2017-11-23
WO2007071334A3 (en) 2007-09-13
RU2008124974A (ru) 2009-12-27
HK1127995A1 (en) 2009-10-16
JP2009520716A (ja) 2009-05-28
KR101449763B1 (ko) 2014-10-13
RU2426552C2 (ru) 2011-08-20

Similar Documents

Publication Publication Date Title
LU93189I2 (fr) Ixekizumab et ses dérivés pharmaceutiquement acceptables (TALTZ)
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
MY148609A (en) Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
WO2006107745A3 (en) Composition for treatment of menopause
NO20075344L (no) Metforminbaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse
LU93096I2 (fr) Evolocumab et ses dérivés pharmaceutiquement acceptables (repatha)
WO2006079550A3 (en) Alcohol resistant dosage forms
PL360495A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
LU92338I2 (fr) Enzalutamide et ses sels pharmaceutiquement acceptables (XTANDI)
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
AR058780A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
NO20084253L (no) Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon
WO2001056573A8 (en) Use of cox-2 inhibitors as gastroprokinetics
WO2005046611A3 (en) Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease
WO2008062376A3 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
CL2012000024A1 (es) Composicion farmaceutica que comprende 100 a 2000 mg de metformina y 10 a 300 mg de un compuesto inhibidor de sglt-2 derivado de glucopiranosil fenil sustituidos, celulosa microcristalina, un aglutinante y croscaramelosa.
NO20084826L (no) Ny administrasjonsform av racecadotril
TW200714586A (en) Crystalline forms of a biphenyl compound
MEP54608A (en) Arylmethylamine derivatives for use as tryptase inhibitors
EP2035963A4 (en) Efficient phrase pair extraction from bilingual word alignments
NO20080697L (no) Modifiserte farmasoytiske doseringsformer for frigivelse av syklooksygenase enzyminhibitor
CR8220A (es) Composicion de fexofenadina y proceso para su preparacion
WO2005084654A3 (en) Methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
NO20032371L (no) Makrolidsolvater